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THE ROLE OF OSTEOPONTIN IN THE DEVELOPMENT  
OF THE HEART VALVE CALCIFICATION 
 
I. A. Morozova, I. M. Zakorko, R. A. Moskalenko 
Relevance: Calcific aortic valve stenosis (CAVS) is an important 
clinical problem affecting 2.8% of adults over 75 years of age in the 
developed countries. Studies suggest that the progression of CAVS is 
actively regulated with valve endothelial injury leading to inflammation, 
fibrosis and calcification. Multiple biological pathways are responsible for 
aortic valve degeneration, with studies suggesting that the progression of 
CAVS is triggered by injury to the valve’s endothelial cell lining and is 
actively regulated. In addition to endothelial cell loss, injury leads to 
infiltration of circulating inflammatory cells, extracellular matrix 
deposition and concomitant activation of proinflammatory cytokines.  
Identifying markers that play a role in the pathogenesis of CAVS is 
therefore crucial in understanding the progression of this disease and may 
reveal potential therapeutic targets for its treatment. Indeed, similar to 
vascular smooth cells, valvular interstitial myofibroblast-like cells showed 
expression osteopontin, osteocalcin, and Runx2, which suggests an active 
mineralization process prior to the development of end-stage calcification 
(macrocalcification). Osteopontin (OPN) was originally linked to bone 
mineralization, but has since been shown to be a multifunctional 
proinflammatory cytokine with important roles in promoting inflammation 
and tissue remodelling including fibrosis and angiogenesis. 
Objective: To analyze English articles in foreign scientific journals 
regarding the role of osteopontin in the development of calcification. 
Materials and Methods: 17 English-language articles were 
analyzed, they have been placed in the public domain on the website Pub 
Med. All articles were published in the professional journals, which are the 
members of the scientific register SCOPUS. 
Research results: OPN is an acidic phosphoprotein normally 
found in mineralized tissues such as bones and teeth, and it is involved in 
regulation of mineralization by acting as an inhibitor of apatite crystal 
growth, as well as promoting osteoclast function. Although OPN is not 
found in normal arteries, but some scientists reported, that OPN is abundant 
at sites of calcification in human atherosclerotic plaques and in calcified 
aortic valves. Studies demonstrated that a subset of valve macrophages 
actively synthesize osteopontin protein in aortic valvular tissue. Other 
studies similarly have demonstrated that macrophages may synthesize 
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osteopontin mRNA and contain osteopontin protein in human 
atherosclerotic plaques; therefore, detection of osteopontin in macrophages 
has precedent. It also has been shown by immunohistochemistry. 
Osteopontin binds readily to hydroxyapatite and may mediate adherence of 
osteoblasts and osteoclasts to bone matrix through an arginine-glycine-
aspartate integrin-binding sequence and amplify the calcification. In 
contrast, other literature sources state that osteopontin regulates negatively 
mineral deposit formation, and it is necessary to myofibroblast 
differentiation and activity, which are produced in the response to a 
profibrotic cytokine, transforming growth factor-1. OPN elaborated by 
stromal or inflammatory cells at sites of ectopic mineralization, binds to 
bioapatites and initially physically inhibits crystal growth. Binding of OPN 
to bioapatite simultaneously provides a recognition site and/or 
concentration gradient for macrophages and giant cells thereby leading to 
localized accumulation. 
Conclusion: there is no definitive data about the role of 
osteopontin in the development of calcific aortic valve stenosis, that 
requires further studying. 
 
 
THE NOBEL PRIZE IN PHYSICS 2016: REVIEW 
 
Lisovenko M., group PhEm.-61 
Mulina N. I., Ph.D., EL Advisor 
For the past 120 years, the Nobel Prize has honored scientists for 
discoveries that the committee feels most benefit mankind. And theoretical 
discoveries of topological phase transitions and topological phases of 
matter lead David J. Thouless (the University of Washington, Seattle), 
Duncan M. Haldane (Princeton University) and J. Michael Kosterlitz 
(Brown University) to getting The Nobel Prize in Physics 2016. Their work 
started in the USA in the early 1970s by identifying a completely new type 
of phase transition in 2D systems with topological defects. This became a 
powerful breakthrough in the theoretical understanding of matter mysteries, 
which created new perspectives on the development of innovative 
materials. [1] 
The main idea of this work comprises two main terms – phase 
transition and topology. Phase transition it is a phenomenon when a 
substance suddenly changes its material properties. The simplest example is 
when water turns into ice with dropping temperature. Phase transition does 
